The first Bayonetta took something that was out of the norm at the time and brought it out in the limelight. Female ...

Acoramidis was approved as Attruby™ by the U.S. FDA in November 2024 and was approved as BEYONTTRA by the European Commission in February 2025 and the Japanese Ministry of Health, Labour ...

The Medicines and Healthcare products Regulatory Agency in the UK has approved acoramidis, marketed as BEYONTTRA®, for treating adults with cardiomyopathy due to transthyretin amyloidosis (ATTR-CM).

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for BridgeBio Pharma’s acoramidis.

Acoramidis is approved as Attruby by the U.S. FDA and is approved as BEYONTTRA by the European Commission, Japanese Pharmaceuticals and Medical Devices Agency, and UK Medicines and Healthcare Products ...

Bayonetta developer Platinum Games is hiring for a new online action game, even after many longtime staff departed for other ...

While Bayonetta 3 marked the end of the franchise and its heroine, that wasn’t exactly the original plan for the series. In a new video shared on his YouTube ...

We reckon we'll see our favourite Umbra Witch return in some capacity, but according to Hideki Kamiya, he had big plans for Bayonetta before his departure from the studio (thanks, Nintendo Everything ...